Multidisciplinary Collaboration for Identifying and Managing ADC-Related Ocular Toxicities

In this segment, the expert faculty emphasizes the essential role of multidisciplinary collaboration in detecting and managing ocular toxicities associated with antibody–drug conjugates (ADCs). They highlight that oncology care teams—particularly nurses, nurse practitioners, and pharmacists—are central to capturing early symptoms, triaging urgency, and ensuring appropriate referral to ophthalmology or optometry. The faculty notes that while oncologists introduce toxicities during initial counseling, it is often the extended care team who reinforce education, review supportive care plans, and confirm patient understanding through interactive discussions rather than passive handouts.

The panel underscores the importance of tailoring team workflows to the specific ADC being used, as toxicity severity, monitoring requirements, and supportive care measures differ among agents. By ensuring that all staff members understand these nuances, practices can more effectively guide patients, recognize warning signs, and coordinate timely evaluations. Ultimately, they stress that strong communication across disciplines enhances patient safety, supports adherence, and improves overall care quality.